Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature

Publisher： John Wiley & Sons Inc

E-ISSN： 2042-6984|5|11|1042-1047

ISSN： 2042-6976

Source： INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol.5, Iss.11, 2015-11, pp. : 1042-1047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case Report of a Patient with Hereditary Hemorrhagic Telangiectasia Treated Successively with Thalidomide and Bevacizumab

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-12 ,pp. : 463-470

Karger

Access to resources Recommend Favorite

The Lung in Hereditary Hemorrhagic Telangiectasia

By  

Respiration, Vol. 94, Iss. 4, 2017-08 ,pp. : 315-330

Karger

Access to resources Recommend Favorite

Angiogenesis and Hereditary Hemorrhagic Telangiectasia

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 214-219

Karger

Access to resources Recommend Favorite

Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double‐blind, randomized, placebo‐controlled trial

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 6, 2015-06 ,pp. : 783-787

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 561-563

John Wiley & Sons Inc

Access to resources Recommend Favorite